Acceptance and Commitment Therapy for Coronary Artery Disease
(ACT for CABG Trial)
Trial Summary
The trial protocol does not specify whether you need to stop taking your current medications. However, it mentions that participants using psychotropic medications must have been on them for at least four weeks, suggesting that some medications may be continued.
Research shows that Acceptance and Commitment Therapy (ACT) can improve mental health and quality of life in patients with heart conditions like myocardial infarction (heart attack). It also helps reduce anxiety, which is linked to heart disease, suggesting it could be beneficial for coronary artery disease.
12345Acceptance and Commitment Therapy (ACT) has been used safely in various studies for conditions like anxiety, depression, and promoting physical activity, with no significant safety concerns reported.
12467Acceptance and Commitment Therapy (ACT) is unique because it focuses on helping patients accept their thoughts and feelings rather than trying to change them, which is different from Cognitive Behavior Therapy (CBT) that aims to modify thought patterns. ACT encourages patients to commit to actions that align with their values, potentially improving psychological well-being and quality of life for those with coronary artery disease.
89101112Eligibility Criteria
This trial is for patients with heart disease who are admitted to the UIHC for urgent or elective CABG surgery. Participants must have a phone or device capable of video or audio, be able to consent, and speak English fluently.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Preoperative Appointment
Participants attend a 1.5-hour preoperative appointment with the case-assigned cardiothoracic surgeon and a nurse practitioner.
Treatment
Participants in the ACT Intervention group receive a two-session telehealth ACT intervention, each session lasting 60-90 minutes.
Follow-up
Participants are monitored for safety and effectiveness after treatment, including assessments of anxiety, depression, and inflammation markers.